Literature DB >> 17001282

Cannabinoid self-administration increases dopamine release in the nucleus accumbens.

Paola Fadda1, Maria Scherma, Maria Sabrina Spano, Paola Salis, Valeria Melis, Liana Fattore, Walter Fratta.   

Abstract

In the present study, dopamine release was monitored during cannabinoid self-administration in rats to achieve a detailed understanding of the way in which dopamine mediates the reinforcing effects of cannabinoids. Extracellular dopamine levels were measured in the shell of the nucleus accumbens of either Lister Hooded or Long Evans rats trained to self-administer the cannabinoid CB1 receptor agonist WIN 55,212-2. A significant relationship between extracellular dopamine levels and bar-pressing rates was observed in both strains, as the dopamine content appreciably increased in respect to basal values during cannabinoid intake. Importantly, dopamine was not modified when trained rats were shifted to vehicle self-administration suggesting that an enhanced activity of the mesolimbic dopamine pathway underlies cannabinoid-taking behaviour.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17001282     DOI: 10.1097/01.wnr.0000236853.40221.8e

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  48 in total

1.  Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.

Authors:  L Fattore; Ms Spano; V Melis; P Fadda; W Fratta
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 2.  Animal models of cannabinoid reward.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

3.  Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study.

Authors:  R Androvicova; J Horacek; J Tintera; J Hlinka; J Rydlo; D Jezova; M Balikova; T Hlozek; P Miksatkova; M Kuchar; M Roman; P Tomicek; F Tyls; M Viktorinova; T Palenicek
Journal:  Psychopharmacology (Berl)       Date:  2017-04-12       Impact factor: 4.530

Review 4.  The neurocircuitry of addiction: an overview.

Authors:  M W Feltenstein; R E See
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

5.  Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats.

Authors:  Maria Scherma; Christian Dessì; Anna Lisa Muntoni; Salvatore Lecca; Valentina Satta; Antonio Luchicchi; Marco Pistis; Leigh V Panlilio; Liana Fattore; Steven R Goldberg; Walter Fratta; Paola Fadda
Journal:  Neuropsychopharmacology       Date:  2015-09-21       Impact factor: 7.853

6.  Evaluation of reinforcing and aversive effects of voluntary Δ9-tetrahydrocannabinol ingestion in rats.

Authors:  Daniel G Barrus; Timothy W Lefever; Jenny L Wiley
Journal:  Neuropharmacology       Date:  2018-05-03       Impact factor: 5.250

Review 7.  Cannabis and psychosis/schizophrenia: human studies.

Authors:  Deepak Cyril D'Souza; Richard Andrew Sewell; Mohini Ranganathan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-16       Impact factor: 5.270

Review 8.  Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate.

Authors:  K Rea; M Roche; D P Finn
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

9.  The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism.

Authors:  Murat Oz; Vanaja Jaligam; Sehamuddin Galadari; George Petroianu; Yaroslav M Shuba; Toni S Shippenberg
Journal:  J Neurochem       Date:  2009-12-24       Impact factor: 5.372

10.  Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users.

Authors:  Daniel S Albrecht; Patrick D Skosnik; Jennifer M Vollmer; Margaret S Brumbaugh; Kevin M Perry; Bruce H Mock; Qi-Huang Zheng; Lauren A Federici; Elizabeth A Patton; Christine M Herring; Karmen K Yoder
Journal:  Drug Alcohol Depend       Date:  2012-08-19       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.